Log on / register
Feedback | Support | My details

Comments

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

José M Navarro-Jarabo email, Nuria Fernández email, Francisca L Sousa email, Encarnación Cabrera email, Manuel Castro email, Luz M Ramírez email, Robin Rivera email, Esther Ubiña email, Francisco Vera email, Isabel Méndez email, Francisco Rivas-Ruiz email, José L Moreno email and Emilio Perea-Milla email

BMC Gastroenterology 2007, 7:31doi:10.1186/1471-230X-7-31

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated